Characteristics and Clinical Presentation of Optic Neuropathy Patients with HIV in Eye Polyclinic of Sanglah General Hospital Denpasar from January 2019 – December 2020
Main Article Content
Keywords
Human Immunodeficiency Virus (HIV), optic neuropathy, CD4
Abstract
Purpose: Human Immunodeficiency Virus (HIV) is a virus that attacks the immune system, complemented by clinical, immunological, and virological disorders. Ocular manifestations were reported in 54% of patients with HIV in Indonesia, with manifestations of posterior segment abnormalities in HIV. This study aims to determine the characteristics and clinical features of optic neuropathy patients with HIV in the Eye Polyclinic of Sanglah General Hospital Denpasar.
Methods: This is a case series study within an observational cross-sectional approach. Data were collected retrospectively by recording the characteristics and clinical features of optic neuropathy in HIV patients at the Eye Polyclinic Sanglah General Hospital Denpasar based on medical records from January 2019 to December 2020. The subjects in this study were 16 people. Characteristics male gender dominates optic neuropathy patients with HIV with 13 patients (81.25%), range of 20-40 years (68.75%).
Results: Decreased visual acuity is the most clinical presentation found in optic neuropathy patients with HIV in this study with 16 patients (100%), with edemapapil in 10 patients (62.5%), atrophy in 6 patients (37.5%). Positive CMV laboratory test results were found in 15 patients (93.75%), the duration of HIV diagnosis to the diagnosis of optic neuropathy was mostly seen with range time six months to 1 year as many as ten patients (62.5%), with CD4 cell counts <100 cell/mL in 12 patients (75%).
Conclusions: A multidisciplinary approach is needed to diagnose optic neuropathy with HIV to get the proper management, which will affect the patient's quality of life.
References
2. Kemenkes. 2018. Info DATIN Situasi Umum HIV/AIDS dan Tes HIV.Jakarta: Kementrian Kesehatan RI
3. Peters RP; Kestelyn PG; Zierhut M;Kempen JH. 2020. The Changing Global Epidemic of HIV and Ocular Disease. Ocular Immunology And Inflammation.
4. Goldensmith P; Jones RE, et al. 2000. Optic neuropathy as the presenting feature ofHIVinfection:recoveryofvisionwithhighlyactiveantiretroviraltherapy. BrJOpthalmol.84.546.Availableonhttps://bjo.bmj.com/content/84/5/546.8
5. AmericanAcademyOphthalmology.2019-2020.Neuro-ophthalmicmanifestations of infectious diseases. In AAO Staff (eds). Clinical Optics. BCSC Section 5 San Fransisco : AAO p.348-349
6. Copeland R. 2019. Ocular Manifestations of HIV Infection. Viewed July 2nd 2020.Avalaible on https://emedicine.medscape.com/article/1216172-overview
7. Bekele S; Gelaw Y;Tessema F. 2013. Ocular Manifestation Of HIV/AIDS And Correlation With CD4+ Cells Count Among Adult HIV/AIDS Patients In Jimma Town, Ethiopia: A Cross Sectional Study.BMC Ophthalmology2013, 13:20.
8. Odoom AM; Bonney EY; Opoku DK. 2016. Ocular Complication in HIV Positive Patients on Antiretroviral Therapy in Ghana.BMC Ophthalmology, vol 16,134.
9. Demirkaya N; Wit F, et al. 2015. Neuroretinal degeneration in HIV Patients without opportunistic ocular infections in the cART era. AIDS PATIENT CARE and STDs. Vol.29. No 10. DOI: 10.1089/apc.2015.0091
10. ElferinkS;WitmerAN;MeenkenC.2015.TwoCaseReportsofHIVRelatedOptic Neuropathy. Austin Journal Clinical Ophthalmology. Vol.2.Issue4
11. Freeman WR; Natta MLV; Jabs D, et al. 2008. Vision Function in HIV-Infected Individuals without Retinitis : Report of the studies of ocular complications of AIDS Research Group. Elsevier Inc. doi:10.1016/j.ajo.2007.10.013
12. Babu K; Murthy KR; Rajagopalan N; et al. 2009. Vision recovery in human immunodeficiency virus-infected patients with optic neuropathy treated with highly active antiretroviral therapy : a case series. Indian J Ophthalmology. Vol 57. No 4. P.315-316
13. Kumarasamy N, Solomon S, Chaguturu SK, Cecelia AJ, Vallabhaneni S, Flanigan TP. 2005. The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis, 41:1525–8
14. Amsalu,A.,Desta,K.,Nigussie,D.,&Delelegne,D.(2017).Ocularmanifestation andtheirassociatedfactorsamongHIV/AIDSpatientsreceivinghighlyactive antiretroviral therapy in Southern Ethiopia. International journal of ophthalmology, 10(5), 776–781.https://doi.org/10.18240/ijo.2017.05.20
15. LabhRK,ChaudharyM,ShahDN.EyeChangesAmongHIVPositivePatientsOn Antiretroviral Therapy In Nepal. Nepal J Ophthalmol.2016;8(15):62-70.